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The EV-TRACK summary add-on: integration of experimental information in
databases to ensure comprehensive interpretation of biological knowledge on
extracellular vesicles
Introduction
Released in multiple body fluids, EVs protect their
content from degradation and are increasingly consid-
ered for the development of novel clinical applications
such as liquid biopsy tests [1–3]. The development of
these tests is currently mainly driven by in-depth ana-
lysis of the protein and RNA cargo of EVs using omics
approaches to identify biomarkers for disease. In addi-
tion, researchers aim to delineate EV functions in
(patho)physiological conditions by integrating this
knowledge on EV cargo [4].
Detection of EV-associated protein and RNA is highly
valuable [5–7] but remains a challenge. Not all extracel-
lular RNA and proteins are associated with EVs. Other
extracellular macromolecular structures overlapping in
size and/or density with EVs, such as protein aggregates,
ribonucleoproteins and lipoprotein particles, contain
RNA and proteins and are frequent contaminants in EV
preparations [8–11]. Both the EV source and the method
of choice determine the degree of specificity to which
these contaminants can be separated from EVs [12].
A multitude of methods have become available to sepa-
rate EVs from biofluids but each method achieves this
with different specificity and efficiency, resulting in
method-dependent identification of EV cargo [13,14].
To allow for the interpretation of contaminant-induced
bias and to ensure reproducibility, transparent reporting
of EV separation and characterization is crucial. To pro-
mote transparent reporting and reproducibility we
released the open-source knowledgebase EV-TRACK
that centralizes (meta) data of EV separation and char-
acterization [13]. Currently, EV-TRACK includes experi-
mental parameters of 2165 EV experiments from 1355
publications. For each experiment, the completeness of
reporting the generic and method-specific information
that facilitates interpretation and reproduction of the
experiment is assessed by a checklist, summarized into
the EV-METRIC (13; evtrack.org/about.php). Supported
by the community, EV-TRACK has been included in the
2018 update of the MISEV guidelines (Minimal
Information for Studies of Extracellular Vesicles) [15].
To enhance validation of EV-associated biomarkers and
functions and, in general, to centralize knowledge on EV
cargo, a multitude of databases have been created. EV-
contained RNA and/or proteins are accessible on specia-
lized databases such as EVpedia, Vesiclepedia, Exocarta,
and more recently ExoRbase and EVmiRNA [16–20].
These databases are driven by community annotation and
present cargo information retrieved using a variety of
separation methods. Dependent upon the specificity of
the method, this cargo thus associates with differential
likelihood to EVs or extracellular macromolecular struc-
tures. As such, one of the main challenges of these data-
bases is to ensure access to unbiased experimental
information to interpret the EV content and thus to fit
the purpose of biological knowledge discovery. By provid-
ing users the EV-METRIC linked to the EV-TRACK entry
for reported studies, the 2019 update of Vesiclepedia was
a first step towards integrating EV-TRACK knowledge in
EV-related databases [21]. We present here the impor-
tance, development and integration of the EV-TRACK
summary add-on to further integrate experimental infor-
mation relevant to the interpretation of knowledge in data-
bases and thus facilitate true EV cargo and function
discovery using publicly available data.
Development of the EV-TRACK summary
add-on
Currently, experimental information onEV separation and
characterization provided by EV-related databases is lim-
ited and heterogeneously reported between platforms. To
address this issue, we developed an EV-TRACK summary
add-on (Figure 1), which can easily be integrated in EV-
related databases using the following hyperlink http://
www.evtrack.org/study_summary.php?PMID= completed
with the PubMed ID of the specific study. The summary
add-on provides an instant overview of the nine experi-
mental parameters that form the EV-METRIC, a measure
for transparent reporting of separation and characteriza-
tion methods (13; evtrack.org/about.php). Doughnut
charts indicate the proportion of reporting adherence to
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each of the nine experimental parameters (Figure 1).
Where applicable, the study tree provides a schematic over-
view of different EV-related experiments and indicates the
EV-METRIC for each individual study experiment.
Additional experimental information can be viewed by
clicking the EV-TRACK ID hyperlink, which redirects to
the full entry in the EV-TRACK knowledgebase. For
studies that have not yet been recorded in the EV-
TRACK knowledgebase, users following this hyperlink
will be invited to connect to the My EV-TRACK page
and submit the publication for annotation. Once curation
has been completed by EV-TRACK administrators, the
EV-TRACK study summary will be automatically gener-
ated and become available on all EV-related databases
Figure 1. Presentation of the EV-TRACK study summary add-on.
The main page of the summary add-on (upper panel) contains general study information including the number of EV experiments performed, the
origin of EVs (species and sample type) and a summary of the separation protocol reported in the study. The average EV-METRIC value given in the
upper table is detailed in doughnut charts with visualization of the nine components of the EV-METRIC for the individual study experiments.
Depending on the separation and characterization methods implemented, ultracentrifugation specifics, antibody specifics and lysate preparation
are applicable or not. For studies with more than two experiments, the EV-METRIC of individual experiments is represented on a radar chart. The
study tree (lower panel) shows a summary of the separation protocol of study experiments and their individual EV-METRIC. Extended information
on the separation protocols and characterization methods employed for each experiment, can be accessed by clicking on the EV-TRACK ID. For
more information on the composition, calculation and use of the EV-METRIC we refer to [13] and evtrack.org/about.php. Abbreviations: DG: density
gradient; dUC: differential ultracentrifugation.
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providing the hyperlink to the EV-TRACK summary add-
on. This summary add-on will assist data interpretation
and as such enable end-users of EV-related databases to
reliably search data for biological knowledge discovery.
EV-TRACK analysis of ExoRbase and
EVmiRNA-related publications
To illustrate the added value of the EV-TRACK sum-
mary add-on in EV-related databases, we performed an
in-depth analysis of publications that were key to the
development of the recently released ExoRbase and
EVmiRNA databases [17,18].
ExoRbase collects and allows to query publicly available
RNA seq data on EV-associated circRNA, lncRNA and
mRNA identified in blood fromhealthy donors or patients.
At the time of release, ExoRbase contained RNA seq infor-
mation from six experiments (87 samples) that were
retrieved from the NCBI Gene Expression Omnibus. One
published experiment (GSE93078; 2 samples) separated
EVs from serum by differential ultracentrifugation prior
to RNA seq analysis. Five experiments (GSE100206,
GSE99985, GSE100063, GSE100207, GSE100232) sepa-
rated EV-associated RNA from plasma using the
exoRNeasy Serum/PlasmaMaxi kit. For these experiments,
no characterization of studied EVs was available. To com-
plete annotation of identified RNA datasets, Li et al. per-
formed a PubMed search, which resulted in an additional
selection of 77 EV-associated RNA from 18 published
studies. To interpret the transparency and reproducibility
of these studies, we submitted them to the EV-TRACK
knowledgebase and retrieved the EV-METRIC (Figure 2
(a)). One study was not included since the manuscript was
not available in English.
Calculation of the average EV-METRIC per study
revealed that all studies have an EV-METRIC lower than
15%. Almost half of the studies (8/17 or 47%) did not
complete the reporting of a single EV-METRIC parameter,
corresponding to a metric of 0%. EVs were separated from
serum, plasma and cell culture supernatant in respectively
65% (11/17), 23% (4/17) and 12% (2/17) of studies (Figure
2(b)). Since serum contains activated platelet EVs released
after coagulation, EV-associated RNA identified from
serum samples may warrant validation to allow unbiased
consideration [15,22]. Commercially available kits (53%, 9/
17) and differential ultracentrifugation (35%, 6/17) were
most commonly implemented to separate EVs from bio-
fluids (Figure 2(c)). Previous studies have demonstrated
that the choice of separation method impacts the identifi-
cation of EV-associated RNA since each separation
method retrieves EVs with a different specificity [14].
Some of the implemented commercial kits are known to
separate EVs with high efficiency but low specificity,
whereas differential ultracentrifugation separates EVs
with low efficiency and low specificity [3,14]. Especially
in blood, in addition to protein-associated RNA, notable
RNA contamination sources include lipoprotein particles
such as HDL and LDL. These are known to transport
miRNA [23] and are prone to co-separation with EVs
due to overlapping size or density. Thus, association of
specific RNA to EVs requires further validation. Electron
microscopy (EM), western blot (WB) and nanoparticle
tracking analysis (NTA) were the most implemented char-
acterization methods, being performed in at least one
experiment in respectively 65% (11/17), 47% (8/17) and
35% (6/17) of studies. Almost 30% (5/17) of studies did not
characterize EVs used for downstream RNA analysis
(Figure 2(d)). Combined RNase and protease treatment
prior to RNA isolation to demonstrate the protection of
identified RNA by a lipid membrane [24] was not per-
formed in at least one experiment in the analysed studies,
while 18% (3/17) of studies performed a RNase only treat-
ment in at least one experiment (Figure 2(f)).
The EVmiRNA database allows to query EV-associated
miRNA expression profiles obtained frommultiple human
biofluids and cell culture supernatant from normal or dis-
ease-related samples (Figure 2(b)) [17]. At the time of
release, the database included EVmiRNA datasets publicly
available on NCBI Sequence Read Archive from 24 pub-
lished studies. EV-TRACK analysis of these studies
revealed that 54% (13/24) of studies did not complete the
reporting of a single EV-METRIC parameter, while 20% of
studies had an average EV-METRIC between 35 and 60%
(Figure 2(a)). Methods used to separate EVs from biofluids
were diverse, with 42% (10/24) of studies using the com-
mercially available ExoQuick kit and 21% (5/24) using
density-based separation. Pelleting of EVs by differential
ultracentrifugation was the most represented strategy to
separate EVs (46% or 11/24 studies) (Figure 2(c)). EM,
WB and NTAwere the main methods used to characterize
EVs and were performed for at least one experiment in
respectively 58% (14/24), 46% (11/24) and 25% (6/24) of
studies. Strikingly, in almost 40% of studies (9/24) no
characterization was performed of the EVs prior to RNA
isolation (Figure 2(d)). Less than 10% of studies (2/24)
controlled for RNA association to EVs by using
a combined protease/RNase treatment in at least one
experiment (Figure 2(f)).
Altogether, only 6% of study experiments (7/117)
available in ExoRbase and EVmiRNA upon their release
obtained an EV-METRIC above 50%. A significant pro-
portion (58% or 68/117) failed to adhere to a single
component of the EV-METRIC and no characterization
of EV was performed in 48% (56/117) of study experi-
ments (Figure 2(e)). This result is consistent with the
previous EV-TRACK analysis of EV-related publications,
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Figure 2. EV-TRACK analysis of ExoRbase and EVmiRNA publications.
Studies considered in ExoRbase as experimental validation studies for blood-EV RNA (50 individual EV experiments, 17 studies) and studies contributing to
EVmiRNA datasets (67 individual EV experiment, 24 studies) were submitted to EV-TRACK and analysed. For each study, the average EV-METRICwas calculated
based on the reporting of the separation and characterization components represented in Figure 1 [13]. The number of experiments in studies achieving
a certain EV-METRIC is indicated in brackets (a). The percentage of studies separating EVs from a given sample type (b), using a selected EV separationmethod
(c), and implementing a RNase and/or protease treatment prior to RNA isolation in at least one experiment (f) are represented in pie charts. The most
frequently performed EV characterization methods are represented as the percentage of studies using a given method to characterize EVs in at least one
experiment (d). The total number of experiments characterized with a given method are indicated on top of the bars. The percentage of studies and the total
number of experiments performing no EV characterization are also included (d). The average EV-METRIC achieved by experiments in function of the number of
methods employed to characterize EVs is represented in (e). The number of experiments concerned is indicated. Characterizationmethods considered for this
analysis include western blot (WB), nanoparticle tracking analysis (NTA), dynamic light scattering (DLS), enzyme-linked immunosorbent assay (ELISA), electron
microscopy (EM), immunoelectron microscopy (IEM), density gradient (DG), density cushion (DC), proteomics and flow cytometry after specific tetraspanin-
mediated association of EVs with beads. Abbreviations: dUC: differential ultracentrifugation.
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where the EV-METRIC was above 50% for less than 6%
of study experiments and 0% for approximately 30% of
study experiments [13]. EV-TRACK analysis of studies
included in ExoRbase and EVmiRNA reveals that the EV-
associated nature of identified RNA species should be
interpreted with care and shows that integration of
the EV-TRACK summary add-on can facilitate this
interpretation.
Concluding remarks and future perspectives
EVpedia (http://evpedia.info/ [16]), EVmiRNA (http://
bioinfo.life.hust.edu.cn/EVmiRNA [17]), ExoRbase
(www.exoRBase.org/ [18]), Exocarta (www.exocarta.
org/ [19]) and Vesiclepedia (www.microvesicles.org/
[20]), are EV-related databases that aim to centralize
knowledge and enable queries on EV cargo including
proteins, nucleic acids and lipids for biomarker and
functional discovery. These databases combine EV
cargo information that 1) has been collected using
different separation methods to extract EVs from bio-
fluids, and 2) has not been well characterized and
validated, as demonstrated by the absence of EV char-
acterization in 1/3 of studies analysed (34%), and the
lack of a combined protease/RNase treatment to vali-
date RNA encapsulation in EVs (5% or 2/41 studies).
Efficient separation of EVs from biofluids and identi-
fication of their cargo are challenging due to the high
complexity of biofluids and the relatively low numbers
of EVs, respectively [11]. As such, the choice of separa-
tion method influences the identification of EV cargo
[14]. In addition, a set of quality control experiments in
compliance with MISEV2018 guidelines needs to be
completed prior to associating cargo with EVs [15].
The EV-TRACK knowledgebase was developed with
the aim to coach researchers in transparent reporting
by implementing the EV-METRIC, a minimal set of
experimental parameters that improve the interpreta-
tion and reproducibility of EV experiments. By devel-
oping the EV-TRACK summary add-on, we aim to
extend this coaching to other EV-related databases
[23]. The summary add-on will assist researchers in
the interpretation of the data, and will steer reliable
data selection to increase the discovery of biological
knowledge.
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